购物车里还没有商品。
特色
描述
研究领域
Product Categories/Research Area,Product Categories/Antibodies,Epigenetics,Product Categories/Products/Antibodies/Primary Antibodies,Product Categories/Products/Antibodies
图片与验证
−
Item 1 of 3
| 已测应用 | IF, WB |
|---|---|
| 稀释范围 | WB: 1:500-2000, IHC-P: 1:50-200 |
| 反应性 | Human |
关键属性
−| 抗体类型 | Primary Antibody |
|---|---|
| 宿主 | Rabbit |
| 克隆性 | Polyclonal |
| 免疫原 | Recombinant full length protein of human Chitotriosidase |
| 靶点 | CHIT1 |
| 偶联 | Unconjugated |
储存与操作
−| 储存 | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| 缓冲液/防腐剂 | Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. |
| 有效期 | 12 months from date of receipt. |
| 免责声明 | For research use only |
别名
−Chitotriosidase-1; Chitinase-1
相似产品
−- Item 1 of 1
质量保证
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.
按应用筛选
按种属筛选
N Przysucha, M Paplińska-Goryca, K Górska, P Misiukiewicz-Stępień, M Mlącki, A Cyran Exploring CHIT1 and YKL-40 in tuberculous pleural effusion: insights and implications researchsquare.com, (2024)
应用
IHC
反应性
Human
Sklepkiewicz, Piotr et al. Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis Eur J Pharmacol, 919, 174792 (2022)
B, Dymek et al. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis Journal of inflammation research, 15, (2022)
